Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass.
Gennero I, Laurencin-Dalicieux S, Conte-Auriol F, Briand-Mésange F, Laurencin D, Rue J, Beton N, Malet N, Mus M, Tokumura A, Bourin P, Vico L, Brunel G, Oreffo RO, Chun J, Salles JP.
Gennero I, et al. Among authors: briand mesange f.
Bone. 2011 Sep;49(3):395-403. doi: 10.1016/j.bone.2011.04.018. Epub 2011 May 1.
Bone. 2011.
PMID: 21569876
Free PMC article.